comparemela.com

Latest Breaking News On - Ins018 055 - Page 1 : comparemela.com

First Drug Designed With Generative AI Enters Phase II Trials

The drug, INS018 055, which was created using generative AI, has been given to patients for the first time in the Phase II clinical trial.

Ins018 055Clinical trailInsilico medicine

Insilico Medicine announces positive topline results of the New Zealand Phase 1 trial of INS018_055, an AI-designed drug for an AI-discovered target

Insilico Medicine (“Insilico”), a clinical stage artificial intelligence (AI)-driven drug R&D company, today announces positive topline results of safety,

New zealandNew yorkUnited statesSujata raoAlex zhavoronkovFeng renInsilico medicineGlobal clinical developmentChief scientific officerNew zealand phaseInternet news presswireEditorial guidelinesIns018 055Ai designedKai discovered

vimarsana © 2020. All Rights Reserved.